Rhumbline Advisers Grows Position in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Rhumbline Advisers grew its holdings in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 6.3% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 107,205 shares of the biotechnology company’s stock after purchasing an additional 6,377 shares during the […]